This inventor holds 1 USPTO granted patent. Top assignees: China Medical University Hospital, The University of North Carolina at Chapel Hill. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 21 
1 out of 1,331 
Years Active: 2017
Title: Zhi-Jun Zhang: Innovator in Antitumor Agents
Introduction
Zhi-Jun Zhang is a notable inventor based in Lanzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumor agents. His innovative work focuses on novel compounds that have the potential to treat various types of cancer.
Latest Patents
Zhi-Jun Zhang holds 1 patent related to his research. The patent involves novel 20-sulfonylamidine derivatives of camptothecin, a compound known for its antitumor properties. This invention outlines a method for synthesizing these derivatives and their application as antitumor agents, specifically targeting nasopharyngeal, lung, breast, or prostate cancer.
Career Highlights
Throughout his career, Zhi-Jun Zhang has worked with prestigious institutions, including China Medical University Hospital and the University of North Carolina at Chapel Hill. His experience in these organizations has allowed him to advance his research and collaborate with other experts in the field.
Collaborations
Zhi-Jun Zhang has collaborated with notable colleagues such as Kuo-Hsiung Lee and Keduo Qian. These partnerships have contributed to the success of his research and the development of innovative solutions in cancer treatment.
Conclusion
Zhi-Jun Zhang's work in developing novel antitumor agents showcases his dedication to advancing medical science. His contributions have the potential to significantly impact cancer treatment and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile